These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 10885656)
21. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation. Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486 [TBL] [Abstract][Full Text] [Related]
22. Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies. Wakabayashi K; Yoshimoto M; Fukushima T; Koide R; Horikawa Y; Morita T; Takahashi H Neuropathol Appl Neurobiol; 1999 Oct; 25(5):363-8. PubMed ID: 10564525 [TBL] [Abstract][Full Text] [Related]
23. Lewy body pathology in late-onset familial Alzheimer's disease: a clinicopathological case series. Tsuang DW; Riekse RG; Purganan KM; David AC; Montine TJ; Schellenberg GD; Steinbart EJ; Petrie EC; Bird TD; Leverenz JB J Alzheimers Dis; 2006 Aug; 9(3):235-42. PubMed ID: 16914833 [TBL] [Abstract][Full Text] [Related]
24. Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies. Fujishiro H; Tsuboi Y; Lin WL; Uchikado H; Dickson DW Acta Neuropathol; 2008 Jul; 116(1):17-24. PubMed ID: 18446351 [TBL] [Abstract][Full Text] [Related]
25. Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease. Lippa CF; Schmidt ML; Lee VM; Trojanowski JQ Arch Neurol; 2001 Nov; 58(11):1817-20. PubMed ID: 11708989 [TBL] [Abstract][Full Text] [Related]
26. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342 [TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711 [TBL] [Abstract][Full Text] [Related]
28. [The mechanism of Lewy body formation in Parkinson's disease]. Wakabayashi K; Takahashi H Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441 [TBL] [Abstract][Full Text] [Related]
29. Evidence in favor of Braak staging of Parkinson's disease. Dickson DW; Uchikado H; Fujishiro H; Tsuboi Y Mov Disord; 2010; 25 Suppl 1():S78-82. PubMed ID: 20187227 [TBL] [Abstract][Full Text] [Related]
31. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Schmidt ML; Martin JA; Lee VM; Trojanowski JQ Acta Neuropathol; 1996; 91(5):475-81. PubMed ID: 8740227 [TBL] [Abstract][Full Text] [Related]
32. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases. Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Namba M; Hayashi Y; Nishinaka T; Namba R; Nakashima H; Uéda K; Checler F; Kuroda S Acta Neuropathol; 2003 Oct; 106(4):348-56. PubMed ID: 12883830 [TBL] [Abstract][Full Text] [Related]
33. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099 [TBL] [Abstract][Full Text] [Related]
34. Lewy body-related alpha-synucleinopathy in the aged human brain. Jellinger KA J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835 [TBL] [Abstract][Full Text] [Related]
35. Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation. Broe M; Shepherd CE; Mann DM; Milward EA; Gai WP; Thiel E; Halliday GM Neurotox Res; 2005; 7(1-2):69-76. PubMed ID: 15639799 [TBL] [Abstract][Full Text] [Related]
36. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). Mikolaenko I; Pletnikova O; Kawas CH; O'Brien R; Resnick SM; Crain B; Troncoso JC J Neuropathol Exp Neurol; 2005 Feb; 64(2):156-62. PubMed ID: 15751230 [TBL] [Abstract][Full Text] [Related]
37. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Arawaka S; Saito Y; Murayama S; Mori H Neurology; 1998 Sep; 51(3):887-9. PubMed ID: 9748051 [TBL] [Abstract][Full Text] [Related]
38. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies. Higuchi S; Arai H; Matsushita S; Matsui T; Kimpara T; Takeda A; Shirakura K Exp Neurol; 1998 Sep; 153(1):164-6. PubMed ID: 9743579 [TBL] [Abstract][Full Text] [Related]
39. Controversy: is Parkinson's disease a single disease entity? Yes. Takahashi H; Wakabayashi K Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626 [TBL] [Abstract][Full Text] [Related]
40. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]